Kras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Cancer Cell

• Publication date

  2007-03-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.CCR.2007.01.017PMID 17349581
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumors of the pancreas

  2007cited by this paper
• Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway.

  2006cited by this paper
• Alterations in components of the TGF-beta superfamily signaling pathways in human cancer.

  2006cited by this paper
• Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer.

  2006cited by this paper
• Tumour microenvironment: TGFβ: the molecular Jekyll and Hyde of cancer

  2006cited by this paper
• Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse.

  2006cited by this paper
• PIK3CA Mutations in Intraductal Papillary Mucinous Neoplasm/Carcinoma of the Pancreas

  2006cited by this paper
• International Consensus Guidelines for Management of Intraductal Papillary Mucinous Neoplasms and Mucinous Cystic Neoplasms of the Pancreas

  2006cited by this paper
• Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations.

  2006cited by this paper
• TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition.

  2005cited by this paper
• Smad transcription factors.

  2005cited by this paper
• Disruption of the TGF-β pathway and modeling human cancer in mice

  2005cited by this paper
• Smad4 Dependency Defines Two Classes of Transforming Growth Factor β (TGF-β) Target Genes and Distinguishes TGF-β-Induced Epithelial-Mesenchymal Transition from Its Antiproliferative and Migratory Responses

  2005cited by this paper
• Precursors to Invasive Pancreatic Cancer

  2005cited by this paper
• Disruption of the TGF-beta pathway and modeling human cancer in mice.

  2005cited by this paper
• Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice.

  2005cited by this paper
• Smad4 dependency defines two classes of transforming growth factor {beta} (TGF-{beta}) target genes and distinguishes TGF-{beta}-induced epithelial-mesenchymal transition from its antiproliferative and migratory responses.

  2005cited by this paper
• An Illustrated Consensus on the Classification of Pancreatic Intraepithelial Neoplasia and Intraductal Papillary Mucinous Neoplasms

  2004cited by this paper
• TGF-ß Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia

  2004cited by this paper
• Living with or without cyclins and cyclin-dependent kinases.

  2004cited by this paper
• Stromal fibroblasts in cancer initiation and progression

  2004cited by this paper
• Mouse models of pancreatic cancer: the fur is finally flying!

  2004cited by this paper
• Pathologically and Biologically Distinct Types of Epithelium in Intraductal Papillary Mucinous Neoplasms: Delineation of an “Intestinal” Pathway of Carcinogenesis in the Pancreas

  2004cited by this paper
• Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition.

  2004cited by this paper
• Integration of TGF‐β/Smad and Jagged1/Notch signalling in epithelial‐to‐mesenchymal transition

  2004cited by this paper
• TGF-beta-induced nuclear localization of Smad2 and Smad3 in Smad4 null cancer cell lines.

  2003cited by this paper
• Clinicopathological Correlates of Pancreatic Intraepithelial Neoplasia: A Comparative Analysis of 82 Cases With and 152 Cases Without Pancreatic Ductal Adenocarcinoma

  2003cited by this paper
• Smad-dependent and Smad-independent pathways in TGF-β family signalling

  2003cited by this paper
• Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer.

  2003cited by this paper
• Suppression of BRAF(V599E) in human melanoma abrogates transformation.

  2003cited by this paper
• Incidental pancreatic cysts: clinicopathologic characteristics and comparison with symptomatic patients.

  2003cited by this paper
• TGF-β-induced nuclear localization of Smad2 and Smad3 in Smad4 null cancer cell lines

  2003cited by this paper
• Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer

  2003cited by this paper
• Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse.

  2003cited by this paper
• Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma.

  2003cited by this paper
• Smad-dependent and Smad-independent pathways in TGF-beta family signalling.

  2003cited by this paper
• The Dichotomy in the Preinvasive Neoplasia to Invasive Carcinoma Sequence in the Pancreas: Differential Expression of MUC1 and MUC2 Supports the Existence of Two Separate Pathways of Carcinogenesis

  2002cited by this paper
• The role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors

  2002cited by this paper
• Reactive Oxygen-induced Carcinogenesis Causes Hypermethylation of p16Ink4a and Activation of MAP Kinase

  2002cited by this paper
• Transforming growth factor-β in T-cell biology

  2002cited by this paper
• Transforming growth factor-beta in T-cell biology.

  2002cited by this paper
• Generation of Smad4/Dpc4 conditional knockout mice

  2002cited by this paper
• Epithelial–mesenchymal transitions in tumour progression

  2002cited by this paper
• Molecular pathology of pancreatic cancer.

  2001cited by this paper
• Wildtype Kras2 can inhibit lung carcinogenesis in mice

  2001cited by this paper
• STK11/LKB1 Peutz-Jeghers gene inactivation in intraductal papillary-mucinous neoplasms of the pancreas.

  2001cited by this paper
• Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras.

  2001cited by this paper
• Functions of mammalian Smad genes as revealed by targeted gene disruption in mice.

  2000cited by this paper
• Dpc4 Protein in Mucinous Cystic Neoplasms of the Pancreas: Frequent Loss of Expression in Invasive Carcinomas Suggests a Role in Genetic Progression

  2000cited by this paper
• Haploid loss of the tumor suppressor Smad4/Dpc4 initiates gastric polyposis and cancer in mice

  2000cited by this paper
• Progression model for pancreatic cancer.

  2000cited by this paper
• Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: comparison with conventional ductal adenocarcinomas.

  2000cited by this paper
• Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression.

  2000cited by this paper
• Gastric and duodenal polyps in Smad4 (Dpc4) knockout mice.

  1999cited by this paper
• Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes.

  1998cited by this paper
• Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.

  1996cited by this paper
• PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum.

  1996cited by this paper
• D-type cyclin-dependent kinase activity in mammalian cells

  1994cited by this paper
• Pancreatic carcinoma.

  1992cited by this paper
• Relation of pancreatic duct hyperplasia to carcinoma

  1979cited by this paper

• Genomic alterations in pancreatic cystic neoplasms: from molecular characterization to precision clinical management

  2025cites this paper
• Mucinous Cystic Neoplasms in Male Patients: Histopathological and Molecular Diagnoses

  2025cites this paper
• Loss of Sorting Nexin 10 Accelerates KRAS-Induced Pancreatic Tumorigenesis

  2025cites this paper
• Myc and Kras cooperate in adult acinar cells to drive phenotypic heterogeneity, metastasis, and therapeutic resistance in a novel pancreatic cancer mouse model

  2025cites this paper
• SMAD4 induces opposite effects on metastatic growth from pancreatic tumors depending on the organ of residence

  2025cites this paper
• From Genes to Environment: Elucidating Pancreatic Carcinogenesis Through Genetically Engineered and Risk Factor-Integrated Mouse Models

  2025cites this paper
• Concurrent targeting of GSK3 and MEK as a therapeutic strategy to treat pancreatic ductal adenocarcinoma

  2024cites this paper
• Suppression of dystroglycan function accompanies pancreatic acinar‐to‐ductal metaplasia and favours dysplasia development

  2024cites this paper
• REDOX SIGNALLING IN THE PANCREAS IN HEALTH AND DISEASE.

  2024cites this paper
• Metastatic site influences driver gene function in pancreatic cancer

  2024cites this paper
• STAT3 is a genetic modifier of TGF-beta induced EMT in KRAS mutant pancreatic cancer

  2024cites this paper
• Acvr1b Loss Increases Formation of Pancreatic Precancerous Lesions From Acinar and Ductal Cells of Origin

  2024cites this paper
• Efficient and multiplexed somatic genome editing with Cas12a mice

  2024cites this paper
• Cell of Origin of Pancreatic cancer

  2024cites this paper
• Molecular Classification and Pathogenesis of Pancreatic Adenocarcinoma and Targeted Therapies: A Review.

  2024cites this paper
• Modelling the micro- and macro- environment of pancreatic cancer: from patients to pre-clinical models and back

  2024cites this paper
• Cellular collusion: cracking the code of immunosuppression and chemo resistance in PDAC

  2024cites this paper
• Elimination of oncogenic KRAS in genetic mouse models eradicates pancreatic cancer by inducing FAS-dependent apoptosis by CD8+ T cells.

  2023cites this paper
• Cystic tumor ablation with different concentrations of lauromacrogol solution in an animal model.

  2023cites this paper
• Identification of calcium and integrin-binding protein 1 as a reprogrammed glucose metabolism mediator to restrict immune cell infiltration in the stromal compartment of pancreatic ductal adenocarcinoma

  2023cites this paper
• An NFATc1/SMAD3/cJUN complex restricted to SMAD4-deficient pancreatic cancer guides rational therapies.

  2023cites this paper
• Host Genetic Background Effect on Body Weight Changes Influenced by Heterozygous Smad4 Knockout Using Collaborative Cross Mouse Population

  2023cites this paper
• SMAD4 loss predicts worse overall and distant metastasis‐free survival in patients with resected pancreatic adenocarcinoma

  2023cites this paper
• Antagonism between Prdm16 and Smad4 specifies the trajectory and progression of pancreatic cancer

  2023influential citation
• Hematopoietic progenitor kinase 1 inhibits the development and progression of pancreatic intraepithelial neoplasia

  2023cites this paper
• Drosophila Screening Identifies Dual Inhibition of MEK and AURKB as an Effective Therapy for Pancreatic Ductal Adenocarcinoma.

  2023cites this paper
• High-throughput functional screen identifies YWHAZ as a key regulator of pancreatic cancer metastasis

  2023cites this paper
• KRAS mutation: The booster of pancreatic ductal adenocarcinoma transformation and progression

  2023cites this paper
• Pancreatic cancer: Advances and challenges

  2023cites this paper
• Towards system genetics analysis of head and neck squamous cell carcinoma using the mouse model, cellular platform, and clinical human data

  2023cites this paper
• CircLDLRAD3 inhibits Oral squamous cell carcinoma progression by regulating miR‐558/Smad4/TGF‐β

  2023cites this paper
• STAT3 is a genetic modifier of TGF-beta induced EMT in KRAS mutant pancreatic cancer

  2023cites this paper
• Clinical and Molecular Attributes and Evaluation of Pancreatic Cystic Neoplasm.

  2022cites this paper
• The Desmoplastic Stroma of Pancreatic Cancer: Multilayered Levels of Heterogeneity, Clinical Significance, and Therapeutic Opportunities

  2022cites this paper
• Epithelial and stromal co-evolution and complicity in pancreatic cancer

  2022cites this paper
• It Takes Two to Tango: Potential Prognostic Impact of Circulating TGF-Beta and PD-L1 in Pancreatic Cancer

  2022cites this paper
• Can we predict the progression of premalignant pancreatic cystic tumors to ductal adenocarcinoma?

  2022cites this paper
• HPV-mediated regulation of SMAD4 modulates the DNA damage response in head and neck cancer

  2022cites this paper
• Multiple roles of mothers against decapentaplegic homolog 4 in tumorigenesis, stem cells, drug resistance, and cancer therapy

  2022cites this paper
• Ubiquitous Aberration in Cholesterol Metabolism across Pancreatic Ductal Adenocarcinoma

  2022cites this paper
• SMAD4–201 transcript as a putative biomarker in colorectal cancer

  2022cites this paper
• Clinical significance of pancreatic ductal metaplasia

  2022cites this paper
• Distinct Mechanisms of Innate and Adaptive Immune Regulation Underlie Poor Oncologic Outcomes Associated with KRAS-TP53 Co-Alteration in Pancreatic Cancer

  2022cites this paper
• TGF-β Signaling in Liver, Pancreas, and Gastrointestinal Diseases and Cancer

  2021cites this paper
• The Diverse Applications of Pancreatic Ductal Adenocarcinoma Organoids

  2021cites this paper
• The Multifaceted Role of TGF-β in Gastrointestinal Tumors

  2021cites this paper
• TGFβ Signaling in the Pancreatic Tumor Microenvironment

  2021cites this paper
• Pancreatic cancer.

  2021cites this paper
• Cell of Origin Influences Pancreatic Cancer Subtype.

  2021cites this paper
• The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives

  2021cites this paper
• Heterogeneity in Pancreatic Cancer Fibroblasts—TGFβ as a Master Regulator?

  2021cites this paper
• SMAD4 represses FOSL1 expression and pancreatic cancer metastatic colonization

  2021cites this paper
• Modeling pancreatic cancer in mice for experimental therapeutics.

  2021cites this paper
• Cx43 phosphorylation sites regulate pancreatic cancer metastasis

  2021cites this paper
• Liver and Pancreas

  2021cites this paper
• A cytokine in turmoil: Transforming growth factor beta in cancer.

  2021cites this paper
• Deregulation of Transcription Factor Networks Driving Cell Plasticity and Metastasis in Pancreatic Cancer

  2021cites this paper
• Downregulation of Smad4 expression confers chemoresistance against imatinib mesylate to chronic myeloid leukemia K562 cells

  2021cites this paper
• In vivo Mouse Models of Pancreatic Ductal Adenocarcinoma

  2021cites this paper
• Pathological Changes in Pancreatic Carcinogenesis: A Review

  2021cites this paper
• Molecular alterations in pancreatic tumors

  2021cites this paper
• Pre-clinical Models of Metastasis in Pancreatic Cancer

  2021cites this paper
• Nuclear factor kappa-B contributes to cigarette smoke tolerance in pancreatic ductal adenocarcinoma through cysteine metabolism.

  2021cites this paper
• Systems genetics analysis of oral squamous cell carcinoma susceptibility using the mouse model: current position and new perspective

  2021cites this paper
• Oncogenic KRAS-Induced Feedback Inflammatory Signaling in Pancreatic Cancer: An Overview and New Therapeutic Opportunities

  2021cites this paper
• Smad4 deficiency substitutes Cdkn2b but not Cdkn2a downregulation in pancreatic cancer following induction of genetic events in adult mice.

  2021cites this paper
• Cancer of Exocrine Pancreas

  2021cites this paper
• Pancreatic cancer evolution and heterogeneity: integrating omics and clinical data

  2021cites this paper
• Patient-Derived Xenograft Models of Pancreatic Cancer: Overview and Comparison with Other Types of Models

  2020cites this paper
• The physiological characteristics of the basal microvilli microvessels in pancreatic cancers

  2020cites this paper
• Identification of genomic alterations and associated transcriptomic profiling reveal the prognostic significance of MMP14 and PKM2 in patients with pancreatic cancer

  2020cites this paper
• A pan-cancer analysis reveals nonstop extension mutations causing SMAD4 tumour suppressor degradation

  2020cites this paper
• Vav1 and mutant K-Ras synergize in the early development of pancreatic ductal adenocarcinoma in mice

  2020cites this paper
• Organoid-based ex vivo reconstitution of Kras-driven pancreatic ductal carcinogenesis.

  2020cites this paper
• Epithelial Nr5a2 heterozygosity cooperates with mutant Kras in the development of pancreatic cystic lesions

  2020cites this paper
• Carcinogenesis of Pancreatic Ductal Adenocarcinoma.

  2020cites this paper
• Learning what counting tells us

  2020cites this paper
• It’s not all about the size—characteristics and risk factors for malignancy of mucinous cystic neoplasms of the pancreas

  2020cites this paper
• Loss of Jag1 cooperates with oncogenic Kras to induce pancreatic cystic neoplasms

  2020cites this paper
• Progress in Animal Models of Pancreatic Ductal Adenocarcinoma

  2020cites this paper
• Clinicopathological and Molecular Profiles of Sporadic Microsatellite Unstable Colorectal Cancer with or without the CpG Island Methylator Phenotype (CIMP)

  2020cites this paper
• Poorly differentiated histologic grade correlates with worse survival in SMAD4 negative pancreatic adenocarcinoma patients

  2020cites this paper
• Novel Biomarkers of Invasive IPMN

  2020cites this paper
• Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer

  2020cites this paper
• Beyond just a tight fortress: contribution of stroma to epithelial-mesenchymal transition in pancreatic cancer

  2020cites this paper
• Pancreatic Fibroblast Heterogeneity: From Development to Cancer

  2020cites this paper
• Tumorigenesis

  2020cites this paper
• Ductal vs. acinar? Recent insights into identifying cell lineage of pancreatic ductal adenocarcinoma.

  2019cites this paper
• Immunomodulatory Effects of TGF-β Family Signaling within Intestinal Epithelial Cells and Carcinomas

  2019cites this paper
• Multiple KRAS mutations in the non‐mucinous epithelial lining in the majority of mucinous cystic neoplasms of the pancreas

  2019cites this paper
• Animal Models: Challenges and Opportunities to Determine Optimal Experimental Models of Pancreatitis and Pancreatic Cancer.

  2019cites this paper
• Epithelial-Stromal Interactions in Pancreatic Cancer.

  2019cites this paper
• Inter‐ and intra‐tumor heterogeneity of SMAD4 loss in head and neck squamous cell carcinomas

  2019cites this paper
• Stromal Barriers Within the Tumor Microenvironment and Obstacles to Nanomedicine

  2019cites this paper
• Primary Pancreatic Cystic Neoplasms

  2019cites this paper
• Molecular Carcinogenesis

  2019cites this paper
• A bibliometric study on pancreatic cystic disease research

  2019cites this paper
• Implication du TGFβ dans le remodelage nerveux associé à l’adénocarcinome canalaire pancréatique

  2019cites this paper
• Immunohistochemically Detected Expression of ATRX, TSC2, and PTEN Predicts Clinical Outcomes in Patients With Grade 1 and 2 Pancreatic Neuroendocrine Tumors

  2019cites this paper
• Genetics and biology of pancreatic cancer and its precursor lesions: lessons learned from human pathology and mouse models

  2019cites this paper